Australia appears to be experience potentially transformative treatment for weight issues: Retatrutide. This dual molecule – targeting on both GLP-1 and GIP receptors – demonstrates significant outcomes in international studies, pointing to substantial decreases in weight. While regulatory clearance is pending with TGA, a number of individuals … Read More